# EDGAR Filing Document

**Accession Number:** 0001393540
**File Stem:** 0001640334-23-000047
**Filing Date:** 2023-1
**Character Count:** 21330
**Document Hash:** 9392a326332af0a09069672c96c7a707
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001640334-23-000047.hdr.sgml**: 20230113

**ACCESSION NUMBER**: 0001640334-23-000047

**CONFORMED SUBMISSION TYPE**: DEF 14C

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230112

**FILED AS OF DATE**: 20230113

**DATE AS OF CHANGE**: 20230112

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** IGEN NETWORKS CORP
- **CENTRAL INDEX KEY:** 0001393540
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-HELP SUPPLY SERVICES [7363]
- **IRS NUMBER:** 205879021
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEF 14C
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-55289
- **FILM NUMBER:** 23526927

**BUSINESS ADDRESS:**
- **STREET 1:** 28375 ROSTRATA AVE
- **CITY:** LAKE ELSINORE
- **STATE:** CA
- **ZIP:** 92532
- **BUSINESS PHONE:** 855-912-5378

**MAIL ADDRESS:**
- **STREET 1:** 28375 ROSTRATA AVE
- **CITY:** LAKE ELSINORE
- **STATE:** CA
- **ZIP:** 92532

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SYNC2 ENTERTAINMENT CORP.
- **DATE OF NAME CHANGE:** 20081009

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NURSE SOLUTIONS, INC.
- **DATE OF NAME CHANGE:** 20070316

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**SCHEDULE 14C**

INFORMATION STATEMENT PURSUANT TO SECTION 14C OF THE

SECURITIES EXCHANGE ACT OF 1934

☒ Filed by the Registrant ☐ Filed by a Party other than the Registrant

Check the appropriate box:

☐ Preliminary Information Statement

☒ Definitive Information Statement Only

☐ Confidential, for Use of the Commission (as permitted by Rule 14c)

---

| |
|:---|
| **IGEN NETWORKS CORPORATION** |
| (Name of Registrant as Specified In Its Charter) |

---

______________________________________________________

Name of Person(s) Filing Information Statement, if other than Registrant:

Payment of Filing Fee (Check the appropriate box):

☒ No fee required.

☐ Fee computed on table below per Exchange Act Rules 14C-5(g) and 0-11.

(1) Title of each class of securities to which transaction applies:

(2) Aggregate number of securities to which transaction applies:

(3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount of which the filing fee is calculated and state how it was determined):

(4) Proposed maximum aggregate value of transaction:

(5) Total fee paid:

☐ Fee paid previously with preliminary materials.

☐ Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11 (a) (2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

(1) Amount previously paid:

(2) Form, Schedule or Registration Statement No.:

(3) Filing Party: ____________________________

(4) Date Filed: ____________________________

IGEN NETWORKS CORP.

31772 Casino Drive, Suite C

Lake Elsinore, CA 92530

844-332-5699

Copies of correspondence to:

Robert J. Burnett

**Witherspoon Brajcich McPhee, PLLC**

601 W. Main Avenue, Suite 1400

Spokane, WA 99201

(509) 455-9077

NOTICE OF ACTION TAKEN WITHOUT A STOCKHOLDER MEETING

Date of Mailing: January 13, 2023

TO THE STOCKHOLDERS OF IGEN NETWORKS CORP.:

The attached Information Statement is furnished by the Board of Directors (the "Board") of IGEN Networks Corp. (the "Company," "we" or "us"). The Company, a Nevada corporation, is a public company registered with the Securities and Exchange Commission.

On December 9, 2022, the Board recommended and approved that the Company amend its Articles of Incorporation to increase the total number of authorized shares of the Company's capital stock by 700,000,000 shares; bringing the total number of authorized shares of capital stock up to 2,900,000,000 shares from 2,200,000,000 shares. Of the 2,900,000,000 authorized shares of capital stock, the authorized shares of Common Stock will consist of 2,890,000,000 shares and the authorized shares of Preferred stock will consist of 10,000,000 shares. All 700,000,000 additional authorized shares will be allocated toward the Company's Common Stock.

On December 9, 2022 stockholders holding 75,428,344 shares of $0.001 par value Common Stock (the "Common Stock") and 5,000,000 shares of $0.001 par value Series B Super Voting Preferred Stock (the "Series B Preferred Stock"), consented to amend the Articles of Incorporation in accordance with the Board's recommendation. Each share of Common Stock has voting power of 1 vote and each share of Series B Preferred Stock has voting power equal to 500 shares of Common Stock. The voted Common Stock and Preferred shares, which equal approximately 60% of the total voting power of the Company's issued and outstanding capital stock, consented in writing to amend the Company's Articles of Incorporation (the "Articles of Amendment"). This consent was sufficient to approve the Articles of Amendment under Nevada law and our Articles of Incorporation. The attached Information Statement describes the Articles of Amendment that the stockholders of the Company have approved, which will increase the Company's authorized shares of capital stock to 2,900,000,000 shares from 2,200,000,000 shares, of which 2,890,000,000 will be Common Stock, and 10,000,000 will be Preferred Stock, with the Preferred shares having such rights and preferences as set by the Board of Directors from time to time. The Articles of Amendment will become effective upon filing with the Nevada Secretary of State, which can occur no earlier than twenty (20) calendar days after the filing and dissemination of the Definitive Information Statement.

NO VOTE OR OTHER ACTION OF THE COMPANY'S STOCKHOLDERS IS REQUIRED IN CONNECTION WITH THIS INFORMATION STATEMENT. WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND US A PROXY.

There are no stockholder dissenters' or appraisal rights in connection with any of the matters discussed in this Information Statement.

Please read this Notice and Information Statement carefully and in its entirety. It describes the terms of the actions taken by the stockholders.

Although you will not have an opportunity to vote on the approval of the Articles of Amendment, this Information Statement contains important information about the Articles of Amendment.

By Order of the Board of Directors <br> Neil Chan, CEO

IMPORTANT NOTICE REGARDING THE AVAILABILITY OF INFORMATION STATEMENT MATERIALS IN CONNECTION WITH THIS NOTICE OF STOCKHOLDER ACTION BY WRITTEN CONSENT:

IGEN NETWORKS CORP.

31772 Casino Drive, Suite C

Lake Elsinore, CA 92530

844-532-5699

INFORMATION STATEMENT

WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND US A PROXY

This Information Statement is being furnished to the stockholders of IGEN Networks Corp., a Nevada corporation (the "Company," "we" or "us"), to advise them of the corporate actions authorized by written consent of the Company's Common Stock and Series B stockholders who hold approximately 60% of the total voting power of the Company's capital stock as of December 9, 2022. These actions are being taken without notice, meetings or votes in accordance with Article 78 of the Nevada Revised Statutes (NRS), the Company's Articles of Incorporation and its Bylaws. This Information Statement is being mailed to the stockholders of the Company, as of January 4, 2023 (the "Record Date").

On December 9, 2022, the Board of Directors approved, and recommended to the stockholders for approval, an amendment to the Company's Articles of Incorporation (the "Articles of Amendment") that will increase the Company's authorized shares of capital stock to 2,900,000,000 shares from 2,200,000,000 shares, of which 2,890,000,000 shares will be Common Stock and 10,000,000 shares will be Preferred Stock, with the Preferred shares having such rights and preference as set by the Board of Directors from time to time. The full text of the Articles of Amendment is attached to this Information Statement as Appendix A.

On December 9, 2022, stockholders holding 75,428,344 shares of Common Stock and 5,000,000 shares of Series B Preferred Stock, each Series B Preferred share having the voting power equal to 500 shares of Common Stock, or approximately 60% of the total voting power of the Company's capital stock consented in writing to the Articles of Amendment. This consent was sufficient to approve the Articles of Amendment under Nevada law.

NO VOTE REQUIRED

We are not soliciting consents to approve the Articles of Amendment. Nevada law and our Articles of Incorporation permit the Company to take any action which may be taken at an annual or special meeting of its stockholders by written consent, if the holders of a majority of the shares of capital stock entitled to vote on such matter sign and deliver to the Company a written consent to the action.

NO APPRAISAL RIGHTS

Under Nevada corporate law, stockholders have no appraisal or dissenters' rights in connection with the Articles of Amendment.

INTERESTS OF CERTAIN PARTIES IN THE MATTERS TO BE ACTED UPON

None of the directors or executive officers of the Company has any substantial interest resulting from the Articles of Amendment that is not shared by all other stockholders pro rata, and in accordance with their respective interests.

COST OF THIS INFORMATION STATEMENT

The entire cost of furnishing this Information Statement will be borne by us. We will request brokerage houses, nominees, custodians, fiduciaries and other like parties to forward this Information Statement to the beneficial owners of our Common Stock held of record by them.

HOUSEHOLDING OF STOCKHOLDER MATERIALS

In some instances, we may deliver only one copy of this Information Statement to multiple stockholders sharing a common address. If requested by phone or in writing, we will promptly provide a separate copy to a stockholder sharing an address with another stockholder. Requests should be directed to our Chief Executive Officer, Neil G. Chan, 31772 Casino Drive, Suite C, Lake Elsinore, CA 92530, 844-532-5699. Stockholders sharing an address who currently receive multiple copies and wish to receive only a single copy should contact their broker or send a signed, written request to us at the above address.

**AMENDMENT TO THE ARTICLES OF INCORPORATION TO INCREASE THE AUTHORIZED SHARES OF COMMON STOCK.**

**General**

Our Articles of Incorporation currently authorize 2,900,000,000 shares of capital stock, 2,890,000,000 shares of which are Common Stock and 10,000,000 shares of which are Preferred Stock.

On December 9, 2022, the Board of Directors, and the consenting stockholders, approved the filing of an amendment to our Articles of Incorporation to increase the authorized shares of capital stock to 2,900,000,000 shares from 2,200,000,000 shares (the "Amendment"), of which 2,890,000,000 shares will be Common Stock and 10,000,000 shares will Preferred Stock; with the Preferred shares having such rights and preferences as set by the Board of Directors from time to time.

**Reasons for the Increase in Authorized Shares of Common Stock**

Our Articles of Incorporation presently authorize 2,200,000,000 shares of Common Stock. As of December 9, 2022, there were 1,826,013,809 shares of Common Stock issued and outstanding and 5,000,000 shares of Series B Preferred Stock issued and outstanding. In order to provide funding for the Company's operations, development and growth, it will be necessary to issue additional shares of Common Stock, or Preferred shares that may be convertible into Common Stock. The increase in the Company's authorized shares to 2,900,000,000 shares from 2,200,000,000 shares is intended to provide adequate authorized shares to cover the Company's potential financing and/or acquisition needs for at least the next 12 months.

**Effective Date**

Under Rule 14c-2, promulgated pursuant to the Securities Exchange Act of 1934, as amended, the Amendment shall be effective twenty (20) days after this Information Statement is mailed to stockholders of the Company. We anticipate the effective date to be on or about February 02, 2023.

**SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT**

The following table sets forth certain information, as of November 30, 2022, with respect to the holdings of (1) each person who is the beneficial owner of more than 5% of our Common Stock, (2) each of our directors, (3) each executive officer, and (4) all of our current directors and executive officers as a group.

Beneficial ownership of the Common and Preferred Stock is determined in accordance with the rules of the Securities and Exchange Commission and includes any shares of Common Stock over which a person exercises sole or shared voting or investment power, or of which a person has a right to acquire ownership at any time within 60 days of November 30, 2022. Except as otherwise indicated, we believe that the persons named in this table have sole voting and investment power with respect to all shares of common stock held by them. Applicable percentage ownership in the following table is based on 1,804,789,319 shares of Common Stock outstanding as November 30, 2022, plus, for each individual, any securities that individual has the right to acquire within 60 days of November 30, 2022.

---

| | | |
|:---|:---|:---|
| | **Shares Beneficially** | **Shares Beneficially** |
| | **Owned** | **Owned** |
| <br>**Name and Address of Beneficial Owner:** | **Number** | **Percent** |
| *5% Stockholders:* |  |  |
| *Directors and Executive Officers:* |  |  |
| Neil Chan(1) | 39120005 | 2.4% |
| Abel Sierra(2) | 20408170 | 1.0% |
| Robert Nealon(3) | 9939387 | \* |
| Mark Wells | 5960785 | \* |
| All executive officers and directors as a group (4 persons) | 75428347 | 4.2% |

---

_________

\* Represents beneficial ownership of less than 1%.

(1) Represents 1,500,000 shares of Common Stock issuable upon the exercise of stock options that are or will be vested and exercisable within 60 days after November 30, 2022, and 37,620,005 outstanding shares of Common Stock.

(2) Represents 650,000 shares of Common Stock issuable upon the exercise of stock options that are or will be vested and exercisable within 60 days after November 30, 2022, and 19,758,170 outstanding shares of Common Stock. 

(3) Represents 400,000 shares of Common Stock issuable upon the exercise of stock options that are or will be vested and exercisable within 60 days after November 30, 2022, and 9,539,387 outstanding shares of Common Stock. 

**Securities Authorized for Issuance under Equity Compensation Plans**

None

(b) <u>Changes in Control</u>

We know of no arrangements which may at a subsequent date result in a change in control of the Company.

CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING INFORMATION

This Information Statement may contain "forward-looking statements." All statements other than statements of historical fact are "forward-looking statements" for purposes of these provisions, including any projections of earnings, revenues or other financial items, any statement of the plans and objectives of management for future operations, and any statement of assumptions underlying any of the foregoing. These statements may contain words such as "expects," "anticipates," "plans," "believes," "projects," and words of similar meaning. These statements relate to our future business and financial performance.

Actual outcomes may differ materially from these statements. The risks listed in this Information Statement as well as any cautionary language in this Information Statement, provide examples of risks, uncertainties and events that may cause our actual results to differ materially from any expectations we describe in our forward-looking statements. There may be other risks that we have not described that may adversely affect our business and financial condition. We disclaim any obligation to update or revise any of the forward-looking statements contained in this Information Statement. We caution you not to rely upon any forward-looking statement as representing our views as of any date after the date of this Information Statement. You should carefully review the information and risk factors set forth in other reports and documents that we file from time to time with the SEC.

ADDITIONAL INFORMATION

This Information Statement should be read in conjunction with certain reports that we previously filed with the SEC, including our:

\* Annual Report on Form 10-K for the fiscal year ended December 31, 2021; and

\* Quarterly Reports on Form 10-Q for the periods ended June 30, 2022 and September 30, 2022.

The reports we file with the SEC and the accompanying exhibits may be inspected without charge at the Public Reference Section of the Commission at 100 F Street, N.E., Washington, DC 20549. Copies of such materials may also be obtained from the SEC at prescribed rates. The SEC also maintains a Web site that contains reports, proxy and information statements and other information regarding public companies that file reports with the SEC. Copies of the Reports may be obtained from the SEC's EDGAR archives at http://www.sec.gov. We will also mail copies of our prior reports to any stockholder upon written request.

---

| |
|:---|
| By Order of the Board of Directors |
| Neil Chan, CEO |
| Lake Elsinore, CA |
| January 13, 2023  |

---

**APPENDIX A**

**Capital Stock.**

The aggregate number of shares that the Corporation will have authority to issue is Two Billion Nine Hundred Million (2,900,000,000) of which Two Billion Eight Hundred Ninety Million (2,890,000,000) shares will be Common Stock, with a par value of $.001 per share, and Ten Million (10,000,000) shares will be Preferred Stock, with a par value of $.001 per share.

The Preferred Stock may be divided into and issued in series. The Board of Directors of the Corporation is authorized to divide the authorized shares of Preferred Stock into one or more series, each of which shall be so designated as to distinguish the shares thereof from the shares of all other Series B classes. The Board of Directors of the Corporation is authorized, within any limitations prescribed by law and this Article, to fix and determine the designations, rights, qualifications, preferences, limitations and terms of the shares of any series of Preferred Stock including but not limited to the following:

a. The rate of dividend, the time of payment of dividends, whether dividends are cumulative, and the date from which any dividends shall accrue;

b. Whether shares may be redeemed, and, if so, the redemption price and the terms and conditions of redemption;

c. The amount payable upon shares in the event of voluntary or involuntary liquidation;

d. Sinking fund or other provisions, if any, for the redemption or purchase of shares;

e. The terms and conditions on which shares may be converted, if the shares of any Series B issued with the privilege of conversion;

f. Voting powers, if any, provided that if any of the Preferred Stock or series thereof shall have voting rights, such Preferred Stock or series shall vote only on a share for share basis with the Common Stock on any matter, including but not limited to the election of directors, for which such Preferred Stock or series has such rights; and,

g. Subject to the foregoing, such other terms, qualifications, privileges, limitations, options, restrictions, and special or relative rights and preferences, if any, of shares or such Series Bs the Board of Directors of the Corporation may, at the time so acting, lawfully fix and determine under the laws of the State of Nevada.

The Corporation shall not declare, pay or set apart for payment any dividend or other distribution (unless payable solely in shares of Common Stock or other class of stock junior to the Preferred stock as to dividends or upon liquidation) in respect of Common stock, or other class of stock junior to the Preferred stock, nor shall it redeem, purchase or otherwise acquire for consideration shares of any of the foregoing, unless dividends, if any, payable to holders of Preferred stock for the current period (and in the case of cumulative dividends, if any, for all past periods) have been paid, are being paid or have been set aside for payment, in accordance with the terms of the Preferred Stock, as fixed by the Board of Directors.

In the event of the liquidation of the Corporation, holders of Preferred Stock shall be entitled to receive, before any payment or distribution on the Common Stock or any other class of stock junior to the Preferred Stock upon liquidation, a distribution per share in the amount of the liquidation preference, if any, fixed or determined in accordance with the terms of such Preferred Stock plus, if so provided in such terms, an amount per share equal to accumulated and unpaid dividends in respect of such Preferred Stock (whether or not earned or declared) to the date of such distribution. Neither the sale, lease or exchange of all or substantially all of the property and assets of the Corporation, nor any consolidation or merger of the Corporation, shall be deemed to be a liquidation for the purposes of this Article.